HopeStage
Back to all studies
CompletedNCT03013400

Ebselen for Hypomania or Mania in People With Bipolarity

About this titleRead the official source — NCT03013400
Medication studyAges 18–70United Kingdom
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
OxfordSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
University of Oxford
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
From 18 Years to 70 Years
Official registry ID
NCT03013400
Official title
Show the full official title

A Randomised, Parallel Group, Double Blind, Placebo Controlled, Add on Clinical Trial to Investigate Whether the Lithium Mimetic, Ebselen, Can Reduce Symptoms of Hypomania and Mania in Bipolar Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Oxford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Oxford, a university.

Did this study involve medication?

Yes. The study involved medication, including Ebselen and Placebo oral capsule.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies